To buy enough theyd either have the cash or get a loan? Why not just use a debt facility then to fund their needs for the trial. The terms are set and known, the risks can be mananged (as oppossed to fluctuating share price) and planned for, non dilutionary etc.
Ann: PharmAust to present at NWR Virtual Healthcare Conference, page-41
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.010(5.26%) |
Mkt cap ! $71.26M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 18.0¢ | $184.0K | 982.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 176820 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 167405 | 5 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.0¢ |
Change
-0.010 ( 5.26 %) |
||||
| Open | High | Low | Volume | ||
| 19.5¢ | 19.5¢ | 18.0¢ | 438529 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| PAA (ASX) Chart |